EUDAMED status update
Updates continue to be issued from the European Commission concerning EUDAMED in light of the current COVID-19 pandemic. The latest information sets new expectations about the availability of modules and expected activity.
Liliana Teles

Liliana Teles

Regulatory Affairs Manager

EUDAMED is the European Databank on Medical Devices which came into force in May 2011. EUDAMED was created as a central repository for information on market surveillance exchanged between national competent authorities and the European Commission, with the purpose of strengthening surveillance and transparency with regards to medical devices placed on the European market.

The new regulations on medical devices (MDR) and on in vitro diagnostic medical devices (IVDR) establish a much wider EUDAMED database than the existing one under the current European Directives.

Updates continue to be issued from the European Commission concerning EUDAMED in light of the current COVID-19 pandemic.

The EUDAMED launch has been postponed with a two-year delay compared to initial expectation, until May 2022. However, the European Commission has announced that some modules of EUDAMED will be made available to users before the official EUDAMED date of application in May 2022. Hence, it becomes possible for economic operators to start using EUDAMED before May 2022.

At present, the European Commission has the following implementation plan:

2021 March: the Actor Registration Module will become available. This module will allow for manufacturers, authorized representatives, importers as well as systems and procedure pack producers to enter their data in EUDAMED and to acquire a Single Registration Number (SRN) for declarations of conformity and certificates.

2021 May (expected): the UDI/Device Registration Module and the Certificates and Notified Bodies Modules will be made available (after the Actor module, as soon as functional). At this time, it is anticipated that manufacturers will be able to begin submitting UDI information to EUDAMED.

2022 May: EUDAMED Launch (all modules complete and released, e.g., clinical investigations, incident reporting and market surveillance will become available afterwards as soon as they are functional).

2022 May – 2023 Nov: EUDAMED Device Registration period of 18 months for Legacy, MDR, and IVDR devices.

References:

1. European Commission – European database on medical devices (EUDAMED) – https://ec.europa.eu/growth/sectors/medical-devices/new-regulations/eudamed_en

further
reading

drug_device_combination_1
medical devices

Regulatory Framework of Drug-Device Combination

The advances in technology continue to merge different types of products and the historical lines of separation between medical devices and medicinal products are getting thinner. Products combining medicinal products and medical devices are regulated either by Regulation (EU) 2017/745 (MDR) or by Directive 2001/83/EC.

Read More »
cosmetic products

SCCS Preliminary Opinion on Alpha-Arbutin and Beta-Arbutin

Alpha-arbutin and Beta-arbutin are used in cosmetic with antioxidant, bleaching and skin conditioning functions. Following concerns raised during discussion within the Working Group on Cosmetic Products and consequent call for data on these ingredients, the SCCS assessed the safety of Alpha-arbutin and Beta-arbutin in cosmetic products.

Read More »
cosmetic products

Request for SCCS Scientific Opinion on Citral

The European Commission requested the SCCS to assess whether the derived safe use levels for Citral by the application of the QRA2 based on the induction of skin sensitization is adequate to protect consumers. A period of 9 months was set for issuing the scientific opinion.

Read More »
cosmetic products

SCCS Scientific Advice on the Safety of Triclocarban and Triclosan

The European Commission Scientific Committee on Consumer Safety (SCCS) has published its preliminary version of the scientific advice on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products. The deadline for comments was set at 27 May 2022.

Read More »
cosmetic products

Cosmetic Regulation in the Andean Community

In the Andean Community (Bolivia, Colombia, Ecuador and Peru), cosmetic products are mainly regulated by Decision 833. All cosmetic products made available in these countries must undergo a Mandatory Sanitary Notification (NSO) and need to be manufactured according to Good Manufacturing Practices (GMP).

Read More »
cosmetic products

Cosmetic Product Labelling in the European Union

The Regulation (EC) No 1223/2009 lays down the mandatory information that needs to be included in the packaging and container of a cosmetic products. In addition to this information, most cosmetic products include certain claims, which must be supported and properly substantiated.

Read More »
cosmetic products

Environmental Claims in the UK

Green claims are a trend among consumer goods and services. We often see claims like ‘clean beauty’, ‘environmental friendly’ and so many others. But how can companies ensure that these claims are not misleading? The UK’s Competition and Markets Authority (CMA) has published its Green Claims Code, in order to help companies comply with legal obligations when making environmental claims.

Read More »
cosmetic products

Parabens in Cosmetic Products

Parabens are widely used as preservatives in cosmetic and personal care products. Over the years, there have been some concerns related to the safety of parabens. The SCCS has published several opinions regarding the use of these ingredients in cosmetics, indicating the concentration levels they considered safe for human health. In the EU, some parabens can be safely used as preservatives, while others are prohibited in cosmetic products.

Read More »
cosmetic products

The Product Information File (PIF)

A Product Information File (PIF) is mandatory for all cosmetic products placed in the European Union market. It is a document that compiles the technical information of the cosmetic product and it must be kept for a period of 10 years by the Responsible Person.

Read More »
cosmetic products

How are Cosmetic Products Regulated in Australia?

The Australian Industrial Chemicals Introduction Scheme (AICIS) is the entity responsible for controlling cosmetics and soaps. Cosmetic ingredients are regulated as industrial chemicals under the Industrial Chemicals Act 2019, which is administered by AICIS.

Read More »